Miri Pariente - Rewalk Robotics Global Director - Quality

RWLKDelisted Stock  USD 0.74  0.01  1.33%   

Director

Ms. Miri Pariente is Global Director Quality of ReWalk Robotics Ltd. since April 2013 From 2012 to 2013 Ms. Pariente was the Manager of Quality Assurance at NLT Spine Ltd. a developer of minimally invasive spine procedures and from 2011 to 2012 was the Manager of Quality Assurance at ProAccess Medical Ltd. From 2002 to 2010 Ms. Pariente served in multiple roles within American Medical Systems including Production Supervisor and Lean Leader since 2013.
Age 47
Tenure 11 years
Phone972 4 959 0123
Webhttps://www.rewalk.com
Pariente holds a B.A. in business management from Derby University, England.

Rewalk Robotics Management Efficiency

The company has return on total asset (ROA) of (0.1665) % which means that it has lost $0.1665 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3424) %, meaning that it created substantial loss on money invested by shareholders. Rewalk Robotics' management efficiency ratios could be used to measure how well Rewalk Robotics manages its routine affairs as well as how well it operates its assets and liabilities.
Rewalk Robotics currently holds 897 K in liabilities with Debt to Equity (D/E) ratio of 0.01, which may suggest the company is not taking enough advantage from borrowing. Rewalk Robotics has a current ratio of 21.61, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Rewalk Robotics' use of debt, we should always consider it together with its cash and equity.

Similar Executives

Found 3 records

DIRECTOR Age

Yiftach RothBrainsWay
52
Adi ShmueliInspira Technologies Oxy
N/A
Joel SuiterSurModics
N/A
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Ilit, Israel. Rewalk Robotics operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 51 people. Rewalk Robotics (RWLK) is traded on NASDAQ Exchange in USA and employs 56 people.

Management Performance

Rewalk Robotics Leadership Team

Elected by the shareholders, the Rewalk Robotics' board of directors comprises two types of representatives: Rewalk Robotics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Rewalk. The board's role is to monitor Rewalk Robotics' management team and ensure that shareholders' interests are well served. Rewalk Robotics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Rewalk Robotics' outside directors are responsible for providing unbiased perspectives on the board's policies.
MBA BS, CEO Director
Michael Lawless, Chief Officer
David Hexner, VP RD
Ami Kraft, Ex CEO
Miri Pariente, Global Director - Quality
Jeannine Lynch, Vice Strategy
Kathleen ODonnell, Vice Development
Judy Kula, Human Service
Charles Remsberg, Chief Officer

Rewalk Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Rewalk Robotics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Consideration for investing in Rewalk Stock

If you are still planning to invest in Rewalk Robotics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Rewalk Robotics' history and understand the potential risks before investing.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets